Plain-English translation of NCT06605287 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes Mellitus research guide →This trial tests whether Supaglutide, an injectable medication that helps your pancreas control blood sugar better, can help some people with type 2 diabetes get into remission—meaning they no longer need diabetes drugs and can manage their condition through diet and exercise alone. Researchers will give you this medication for either 7 or 4 months, then stop it and watch carefully over the next year to see if your blood sugar stays controlled without any medication.
Type 2 diabetes is becoming more common, and while diet and exercise are important, many people need medication to control their blood sugar. This study wants to find out if the medication can help 'reset' your pancreas so that it works well enough on its own after treatment stops—something doctors have seen happen with some other treatments, but haven't studied carefully with this newer type of medication yet.
You likely qualify if…
You likely don't qualify if…
You will receive the injectable medication for either 7 months or 4 months. After that, you will stop taking the medication but continue with diet and exercise as your only treatment. The research team will monitor your blood sugar levels and pancreatic function through regular visits and blood tests over the next year, checking at 3 months and 1 year after you stop the medication to see if your diabetes is in remission.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
China